These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

73 related articles for article (PubMed ID: 4148756)

  • 1. [New viewpoints on the effect of beta-receptor blockaders].
    Brisse B; Bräuer B; Müller W; Gradaus D; Bender F
    Med Welt; 1973 Oct; 24(42):1609-10. PubMed ID: 4148756
    [No Abstract]   [Full Text] [Related]  

  • 2. [Therapeutic value of the long-term administration of beta-adrenergic blockaders after myocardial infarct].
    Tomov I
    Vutr Boles; 1984; 23(3):16-25. PubMed ID: 6147044
    [No Abstract]   [Full Text] [Related]  

  • 3. [Intrinsic sympathomimetic activity of adrenergic beta receptor blockaders and its role in various clinical situations].
    Bubiński R
    Pol Tyg Lek; 1984 Dec 17-31; 39(51-52):1713-6. PubMed ID: 6151656
    [No Abstract]   [Full Text] [Related]  

  • 4. Effects of alprenolol on central hemodynamics and exercise tolerance in patients with angina pectoris.
    Jonsson B; Olsson AG; Orö L
    Cardiology; 1973; 58(3):152-61. PubMed ID: 4149331
    [No Abstract]   [Full Text] [Related]  

  • 5. [Treatment of arterial hypertension using beta-blockaders].
    Cottier P
    Ther Umsch; 1974 Nov; 31(11):772-8. PubMed ID: 4154519
    [No Abstract]   [Full Text] [Related]  

  • 6. [Adrenergic beta-blockaders in the treatment of congestive heart failure].
    Longo A
    Rev Port Cardiol; 1993 Nov; 12 Suppl 4():53-9, 9. PubMed ID: 7904459
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Results with new beta receptor blockaders in the therapy of glaucoma].
    Merkle W
    Fortschr Ophthalmol; 1983; 79(5):413-4. PubMed ID: 6135652
    [No Abstract]   [Full Text] [Related]  

  • 8. [Adrenergic beta receptor blockaders in the treatment of mental disorders].
    Bojdecki K
    Psychiatr Pol; 1973; 7(6):655-63. PubMed ID: 4149303
    [No Abstract]   [Full Text] [Related]  

  • 9. [Internal medicine using therapy beta receptor blockaders, especially practolol].
    Kutscha W
    Z Prakt Anasth Wiederbeleb Intensivther; 1972 Dec; 7(6):360-2. PubMed ID: 4405590
    [No Abstract]   [Full Text] [Related]  

  • 10. [Beta-receptor blockaders in pre- and post-menopause].
    Berger M
    Gynakol Rundsch; 1978; 18 Suppl 1():160-1. PubMed ID: 33108
    [No Abstract]   [Full Text] [Related]  

  • 11. Clinical aspects of the anti-arrhythmic actions of beta-receptor blocking drugs. 2. Clinical pharmacology.
    Singh BN
    N Z Med J; 1973 Dec; 78(505):529-35. PubMed ID: 4150209
    [No Abstract]   [Full Text] [Related]  

  • 12. Treadmill investigations into the action of beta receptor antagonists on blood pressure and pulse rate.
    Kirchhoff HW
    Int Z Klin Pharmakol Ther Toxikol; 1970 Dec; 4(1):141-4. PubMed ID: 4395479
    [No Abstract]   [Full Text] [Related]  

  • 13. [Therapy of heart failure. Which patients does the AT1 blocker help?].
    Böhm M
    MMW Fortschr Med; 2003 Sep; 145(38):8. PubMed ID: 14603671
    [No Abstract]   [Full Text] [Related]  

  • 14. Human cardiovascular effects of alprenolol, a beta-adrenergic blocker: hemodynamic, antiarrhythmic, and antianginal.
    Wasserman AJ; Proctor JD; Allen FJ; Kemp VE
    J Clin Pharmacol J New Drugs; 1970; 10(1):37-49. PubMed ID: 4391785
    [No Abstract]   [Full Text] [Related]  

  • 15. [Clinical application of beta-blockaders].
    Offerhaus L
    Ned Tijdschr Geneeskd; 1973 May; 117(21):814-21. PubMed ID: 4150242
    [No Abstract]   [Full Text] [Related]  

  • 16. [Beta blockers in heart failure. Start with low and slowly increase the dosage!].
    MMW Fortschr Med; 2002 Sep; 144(38):59. PubMed ID: 12395713
    [No Abstract]   [Full Text] [Related]  

  • 17. [Beta blockers in heart failure administered with too much reticence. Longevity sacrificed].
    MMW Fortschr Med; 2001 Nov; 143(48):60. PubMed ID: 11770384
    [No Abstract]   [Full Text] [Related]  

  • 18. [Heart failure studies are transferrable to everyday practice. No fear of beta blockers!].
    MMW Fortschr Med; 2002 Oct; 144(44):56. PubMed ID: 12494606
    [No Abstract]   [Full Text] [Related]  

  • 19. Effect of baseline or changes in adrenergic activity on clinical outcomes in the beta-blocker evaluation of survival trial.
    Bristow MR; Krause-Steinrauf H; Nuzzo R; Liang CS; Lindenfeld J; Lowes BD; Hattler B; Abraham WT; Olson L; Krueger S; Thaneemit-Chen S; Hare JM; Loeb HS; Domanski MJ; Eichhorn EJ; Zelis R; Lavori P
    Circulation; 2004 Sep; 110(11):1437-42. PubMed ID: 15337700
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Factorial design in a balanced incomplete block in the evaluation of the minimal active dose of a beta-blocking drug].
    Motolese M
    Boll Chim Farm; 1970 Jun; 109(6):363-8. PubMed ID: 4394953
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 4.